The show featured a presentation on "Curcumin C3 Reduct^® “Integrating Curcumin C3 Reduct^® in new product development" delivered by Dr. Umar Jan, President, Sabinsa European Operations. At the seminar, Dr. Umar underscored the significance of C3 Reduct^® which has been scientifically shown to boost organ health and deliver a range of other targeted functionalities. Curcumin C3 Reduct ^® (Tetrahydrocurcuminoids) is the only Curcumin metabolite product that is approved by EFSA. It is directly and easily assimilated into the body as an active metabolite. At 140mg/ day, C3 Reduct^® delivers functionality without the need for high dosages or added synthetic ingredients. C3 Reduct is EFSA approved Curcumin product as per the EU commission implementing regulation 2022/961.

We sincerely appreciate the attendees for taking the time to learn about our ingredients.